Development and a Randomized Open-Label Controlled Trial of Remote Cardiac Rehabilitation with Wearable Medical Devices
Not Applicable
- Conditions
- Cardiovascular diseases
- Registration Number
- JPRN-UMIN000045024
- Lead Sponsor
- Sakakibara Heart Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1) AMI 2) UAP 3) Pregnancy or nursing 4) uncontrolled arrhythmia 5) uncontrolled AS 6) uncontrolled heart failure 7) acute pulmonary thromboembolism 8) acute myocarditis 9) acute aortic dissection 10) difficulty walking 11) lack of mental capacity 12) pacemaker, implantable cardioverter-defibrillator 13) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cardiac rehabilitation outcomes using Apple Watch in JPRN-UMIN000045024?
How does tele-nursing with wearable devices compare to standard cardiac rehab in post-MI patients?
Which biomarkers predict response to remote cardiac rehabilitation using tele-nursing platforms?
What adverse events are associated with Apple Watch-based cardiac monitoring in heart failure patients?
Are there combination therapies that enhance wearable device-based cardiac rehab efficacy compared to solo interventions?